Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 2
2006 8
2007 6
2008 9
2009 12
2010 12
2011 12
2012 20
2013 12
2014 10
2015 3
2016 6
2017 6
2018 9
2019 9
2020 10
2021 11
2022 10
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Combination antiretroviral therapy.
Domingo P, Vidal F. Domingo P, et al. Among authors: vidal f. Expert Opin Pharmacother. 2011 May;12(7):995-8. doi: 10.1517/14656566.2011.567001. Epub 2011 Mar 24. Expert Opin Pharmacother. 2011. PMID: 21434758
Drug therapies for HIV-related metabolic disorders.
Lamarca K, García Sarasola A, Vidal F, Domingo P. Lamarca K, et al. Among authors: vidal f. Expert Opin Pharmacother. 2016 Jul;17(10):1327-38. doi: 10.1080/14656566.2016.1187133. Epub 2016 May 30. Expert Opin Pharmacother. 2016. PMID: 27192322 Review.
Drug-drug interactions when treating HIV-related metabolic disorders.
Gutierrez MDM, Mateo MG, Corbacho N, Vidal F, Domingo P. Gutierrez MDM, et al. Among authors: vidal f. Expert Opin Drug Metab Toxicol. 2019 Oct;15(10):787-802. doi: 10.1080/17425255.2019.1667334. Epub 2019 Sep 24. Expert Opin Drug Metab Toxicol. 2019. PMID: 31512529 Review.
Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV.
Espineira S, Flores-Piñas M, Chafino S, Viladés C, Negredo E, Fernández-Arroyo S, Mallolas J, Villar B, Moreno S, Vidal F, Rull A, Peraire J. Espineira S, et al. Among authors: vidal f. Front Immunol. 2023 Aug 15;14:1228795. doi: 10.3389/fimmu.2023.1228795. eCollection 2023. Front Immunol. 2023. PMID: 37649488 Free PMC article. Review.
Does choice of antiretroviral drugs matter for inflammation?
Gutierrez MDM, Mateo MG, Vidal F, Domingo P. Gutierrez MDM, et al. Among authors: vidal f. Expert Rev Clin Pharmacol. 2019 May;12(5):389-396. doi: 10.1080/17512433.2019.1605902. Epub 2019 Apr 24. Expert Rev Clin Pharmacol. 2019. PMID: 31017494 Review.
Drug safety profile of integrase strand transfer inhibitors.
Gutierrez Mdel M, Mateo MG, Vidal F, Domingo P. Gutierrez Mdel M, et al. Among authors: vidal f. Expert Opin Drug Saf. 2014 Apr;13(4):431-45. doi: 10.1517/14740338.2014.897327. Epub 2014 Mar 6. Expert Opin Drug Saf. 2014. PMID: 24597519 Review.
167 results